King Wealth Management Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$439K Buy
+7,000
New +$560K 0.05% 111
2022
Q1
Sell
-20,060
Closed -$852K 174
2021
Q4
$852K Sell
20,060
-9,000
-31% -$378K 0.16% 70
2021
Q3
$1.26M Hold
29,060
0.26% 52
2021
Q2
$1.24M Hold
29,060
0.25% 56
2021
Q1
$1.12M Sell
29,060
-8,000
-22% -$303K 0.25% 62
2020
Q4
$1.33M Buy
37,060
+17,000
+85% +$613K 0.31% 52
2020
Q3
$766K Buy
20,060
+60
+0.3% +$2.31K 0.2% 69
2020
Q2
$702K Buy
20,000
+1,000
+5% +$36K 0.21% 67
2020
Q1
$620K Buy
+19,000
New +$742K 0.27% 57

Other funds holding BSX

King Wealth Management Group's BSX Position: Q1 2026 in Review

King Wealth Management Group opened a new position in Boston Scientific (BSX) in Q1 2026: 7,000 shares worth $439K. The stake represents 0.05% of the portfolio and ranks #111 among its holdings. This is a return to the name: King Wealth Management Group previously reported a position in BSX as recently as Q4 2021.

King Wealth Management Group first reported a position in BSX in Q1 2020 and has held it in 9 quarters since. The position peaked at $1.33M in Q4 2020. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • King Wealth Management Group held 7,000 shares of Boston Scientific worth $439K as of Q1 2026.
  • Boston Scientific was a new King Wealth Management Group position in Q1 2026.
  • Boston Scientific made up 0.05% of King Wealth Management Group's portfolio in Q1 2026, its #111 holding.
  • King Wealth Management Group first reported a position in Boston Scientific in Q1 2020 and has held it in 9 quarters since.
  • King Wealth Management Group's Boston Scientific position peaked at $1.33M in Q4 2020.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on King Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.